Vault-13

SINOVAC BIOTECH LTD SVA

SHS · Common Stock · CUSIP P8696W104

Chinese biopharm company

31 institutional holders +26 vs Q1 2023
11,778,63111.8m shares reported held*
$960.9mreported value*
26 new 0 added 1 reduced 0 sold out net bought ≈ $4.3m (+2.8m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $81.58. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).

Trends to Q2 2023

Institutional holders

Managers reporting a position, each quarter

02040Q3 22: 32Q4 22: 10Q1 23: 5Q2 23: 3131Q3 22Q4 22Q1 23Q2 23
Numbers
QuarterHolders
Q3 202232
Q4 202210
Q1 20235
Q2 202331

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
40040Q4 22: 1 bought or addedQ4 22: 22 cut or sold outQ4 22Q1 23: 0 bought or addedQ1 23: 5 cut or sold outQ1 23Q2 23: 26 bought or addedQ2 23: 1 cut or sold outQ2 23
Numbers
QuarterBought or addedCut or sold out
Q4 2022122
Q1 202305
Q2 2023261

Biggest buyers

Biggest sellers

NAVELLIER & ASSOCIATES INC Reduced -407-407

Biggest calls

Biggest puts

Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
1Globe Capital LLC 13D · may seek influence no change · filed 2025-09-12
Stated purposeItem 4 of the Schedule 13D is hereby amended and supplemented as follows: On July 25, 2025, Vivo Capital Surplus Fund VIII, L.P. ("Vivo Fund VIII") filed an amended complaint (the "Amended Complaint") with the U.S. District Court for the Commonwealth of Massachusetts in the civil action initiated by Vivo Fund VIII on April 14, 2025 and previously disclosed in Amendment No. 6 to the Schedule 13D (the "Vivo Action"). In the Amended Complaint, Vivo Fund VIII alleges a disclosure violation claim under Section 13(d) of the Securities Exchange Act of 1934, repeating in a single count the allegations that appeared in its original complaint. Among other things, Vivo Fund VIII alleges that (1) Dr. Li has not filed a Schedule 13D and as a result investors do not know how many Sinovac shares he be… Full filing
32.3% no change 18.5m 2025-09-12
SAIF Partners IV L.P. 13D · may seek influence no change · filed 2025-12-17 15.0% no change 10.8m 2025-12-17
WEIDONG YIN 13D · may seek influence no change · filed 2025-07-15
Stated purposeItem 4 is hereby amended and supplemented to add the following: The Issuer announced on July 10, 2025 a new board of directors of the Issuer (the "Board"), comprising Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y Yan (as Chairman of the Board) and the Reporting Person. The Reporting Person has accepted the appointment and plans to participate in the future governance of the Issuer as a member of the newly Board. Except as set forth in this Item 4, the Reporting Person has no present plan or intention that would resu lt in or relate to the listed transactions described in Item 4 of Schedule 13D. The Reporting Person has engaged and will continue to engage in discussions with other shareholders of… Full filing
8.8% no change 6.4m 2025-07-15
Advantech Capital L.P. 13D · may seek influence no change · filed 2025-07-14
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On July 7, 2025, the High Court of Antigua and Barbuda granted an interim injunction prohibiting the Reporting Persons and certain other shareholders from voting their shares at the Special Meeting (the "Injunction Order"). On July 8, 2025, the Court of Appeal of the Eastern Caribbean Supreme Court issued an order staying the Injunction Order (the "Stay Order"). After the Court of Appeal issued the Stay Order, the Special Meeting of Shareholders of the Issuer requisitioned by SAIF Partners IV L.P. ("SAIF") (the "Special Meeting") was convened. Mr. Chiang Li delivered a short statement and then purported to adjourn the Special Meeting. The Reporting Persons understand that the shareholders attending the Special Meeting the… Full filing
8.1% no change 5.9m 2025-07-14
Vivo Capital VIII, LLC 13D · may seek influence no change · filed 2025-07-11
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On May 19, 2025, the Issuer gave notice of a Special Meeting of Shareholders to be held on July 8, 2025 and announced an intention to exclude shares held by the Reporting Persons and another investor from the vote. On May 30, 2025, the Issuer filed an application for an injunction in the High Court of Antigua and Barbuda seeking an order prohibiting the Reporting Persons and the other investor from voting their shares at the Special Meeting. The Reporting Persons have opposed such an injunction in the High Court and the Court of Appeal of the Eastern Caribbean Supreme Court, and, on July 8, 2025, the Court of Appeal issued an order staying execution of an injunction from the High Court. In light of the Court of Appeal's… Full filing
6.3% no change 4.5m 2025-07-11
Vivo Capital IX, LLC 13D · may seek influence filed 2025-03-19
Stated purposeItem 4 is hereby supplemented and amended by adding the following: On February 28, 2025, the Issuer announced a new Board of Directors (the "New Board"). The New Board purportedly does not include Mr. Shan Fu, the Reporting Persons' Board designee since July 2, 2018. Mr. Fu has been excluded from the Issuer's Board of Directors, and requests for his inclusion have gone unanswered. The Reporting Persons intend to take necessary actions to restore Mr. Fu to the Board. The Issuer's announcement also implies that the New Board will take steps to invalidate the July 2, 2018 Private Placement, through which the Reporting Persons acquired the Issuer's common shares and which provided the Issuer with growth capital essential to its subsequent development of the CoronaVac vaccine. The Reporti… Full filing
6.3% 4.5m 2025-03-19

Insider purchases and sales in Q2 2023

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q2 2023.

Holders, Q2 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Vivo Capital, LLC 42.47% of their portfolio Palo Alto, CA 5,900,0005.9m $615.4m $615.4m 42.47% Unchanged
2 ORBIMED ADVISORS LLC 6.21% of their portfolio New York, NY 2,718,7352.7m $340.0m $340.0m 6.21% Unchanged
3 RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio NEW YORK, NY 2,375,8412.4m $1.5m $1.5m 0.00% New
4 Neumann Advisory Hong Kong Ltd 0.78% of their portfolio CENTRAL, K3 315,586315.6k $2.0m $2.0m 0.78% Unchanged
5 STATE STREET CORP 0.00% of their portfolio BOSTON, MA 160,875160.9k $1.0m $1.0m 0.00% New
6 Yorktown Management & Research Co Inc 0.31% of their portfolio Forest, VA 74,89374.9k $290.6k $290.6k 0.31% New
7 California Public Employees Retirement System 0.00% of their portfolio Sacramento, CA 68,73268.7k $0 $0 0.00% New
8 Skandinaviska Enskilda Banken AB (publ) 0.00% of their portfolio STOCKHOLM, V7 40,00040.0k $259.0k $259.0k 0.00% New
9 Spark Investment Management LLC 0.00% of their portfolio NEW YORK, NY 29,10029.1k $0 $0 0.00% New
10 GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio BOSTON, MA 27,71727.7k $179.3k $179.3k 0.00% New
11 SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio BALA CYNWYD, PA 16,43016.4k $106.3k $106.3k 0.00% New
12 NAVELLIER & ASSOCIATES INC 0.00% of their portfolio Reno, NV 14,64914.6k $0 $0 0.00% Reduced -407 -407
13 NORTHERN TRUST CORP 0.00% of their portfolio CHICAGO, IL 13,78713.8k $0 $0 0.00% New
14 UBS Group AG 0.00% of their portfolio ZURICH, V8 9,0959.1k $58.8k $58.8k 0.00% New
15 MORGAN STANLEY 0.00% of their portfolio NEW YORK, NY 4,5664.6k $29.5k $29.5k 0.00% New
16 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 3,0003.0k $19.4k $19.4k 0.00% New
17 WELLS FARGO & COMPANY/MN 0.00% of their portfolio SAN FRANCISCO, CA 1,6611.7k $10.7k $10.7k 0.00% New
18 OSAIC HOLDINGS, INC. 0.00% of their portfolio SCOTTSDALE, AZ 1,3621.4k $0 $0 0.00% New
19 ROYAL BANK OF CANADA 0.00% of their portfolio TORONTO, A6 533533 $0 $0 0.00% New
20 Clearstead Advisors, LLC 0.00% of their portfolio CLEVELAND, OH 500500 $0 $0 0.00% New
21 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 426426 $0 $0 0.00% New
22 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 424424 $0 $0 0.00% New
23 GROUP ONE TRADING LLC 0.00% of their portfolio CHICAGO, IL 412412 $2.7k $2.7k 0.00% New
24 US BANCORP \DE\ 0.00% of their portfolio MINNEAPOLIS, MN 127127 $0 $0 0.00% New
25 NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.00% of their portfolio MILWAUKEE, WI 108108 $699 $699 0.00% New
26 Horizon Investments, LLC 0.00% of their portfolio Charlotte, NC 5252 $336 $336 0.00% New
27 ASSETMARK, INC 0.00% of their portfolio CONCORD, CA 1414 $0 $0 0.00% New
28 EverSource Wealth Advisors, LLC 0.00% of their portfolio BIRMINGHAM, AL 44 $0 $0 0.00% New
29 Transamerica Financial Advisors, LLC 0.00% of their portfolio CEDAR RAPIDS, IA 22 $0 $0 0.00% New
30 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% New
31 Financial Gravity Asset Management, Inc. 0.00% of their portfolio Lakeway, TX 00 $0 $0 0.00% Unchanged